skip to Main Content
 

Benchmark Survey Results

  • This page as PDF

Summary

A June 2014 Avalere survey asserts that while 90% of pharmaceutical and biotech manufacturers are offering cost-sharing assistance to exchange patients, the type of support, generosity and program structure vary widely.

Panelists

Moderator
Matt Brow , President & General Manager - Pharmacy, Life Sciences & Advisory

Matt Brow serves as the president and general manager of Inovalon’s Pharmacy, Life Sciences and Advisory business.

Sign up to receive more insights about
Please enter your email address to be notified when new insights are published.

Back To Top